In conclusion, these findings suggested that monocyte acted as a protective factor and MMP9/IGFBP1 played a vital role in tumor immune, which might become potential novel biomarkers and therapeutic targets for immunotherapy in ccRCC. The gene discussed is IGFBP1; the disease is nonpapillary renal cell carcinoma.